Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-099791
Filing Date
2024-09-13
Accepted
2024-09-13 16:15:17
Documents
3
Period of Report
2024-09-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2424019d1_6k.htm 6-K 11222
2 EXHIBIT 99.1 tm2424019d1_ex99-1.htm EX-99.1 21796
3 GRAPHIC tm2424019d1_ex99-1img001.jpg GRAPHIC 10292
  Complete submission text file 0001104659-24-099791.txt   48505
Mailing Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076
Business Address PAUL-EHRLICH-STRABE 15 TUBINGEN BADEN-WURTTEMBERG 2M 72076 49 7071 9883 0
CureVac N.V. (Filer) CIK: 0001809122 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39446 | Film No.: 241297908
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)